970*90
768
468
mobile

Success Story Of Dava India That Secured Its Position In Top Franchise 100 Brands List

Shahram Warsi
Shahram Warsi Feb 20 2019 - 3 min read
Success Story Of Dava India That Secured Its Position In Top Franchise 100 Brands List
Currently, 4 stores of Dava India are operational at Surat and Navsari. By March end, 30 more stores will be operational and after that, within two years, there will be more than 3000 stores in different parts of Gujarat and India.

With a vision of transforming the Indian pharmacy and healthcare industry, Dava India under the brand Zota Healthcare Ltd. was launched in September 2017. After generic medicine started to gain immense popularity in India, Zota Healthcare planned to revolutionize the field of medicine through their Dava India brand.

Brand’s Growth Story

In transforming the Indian pharmacy and healthcare industry through generic medicines, Zota Healthcare Pvt Limited has played an essential and major role. The Surat-based company is now among the most reputed pharmaceutical brands in India, having more than 3200 products under its name.

The brand is exporting medicines to almost 18 countries worldwide with over 1200 distributors listed under its name. With great success and a huge network globally, the brand successfully managed to get enlisted into the Top Franchise 100 Brands List.

A Brand Bidding to Common People

After the Prime Minister of India initiated the campaign for generic medicines in India, common people got awakened, realizing the importance of generic medicines. Dava India is dealing with the same initiative by producing generic medicines for common people at affordable pricing. The brand is trying to reduce the burden of treatment by reducing the medicines pricing by almost 30%-90% in the current costly medicines segment.

Currently, Dava India is offering 3,300 medicines for the treatment of numerous diseases such as diabetes, blood pressure, thyroid, health-related ailments, liver & nervous system as well as joint pains and cancer.

Franchise Facts

Investment range: INR 6-7 lakhs

Size: 200 sqft

Expected ROI: 1 year

Expected breakeven: First quarter

Dava India’s Future Plans

After being listed as an NSE & SME company, Zota Healthcare is focusing on strictly adhering all the standard production practices that are recommended by the World Health Organization. Through its Dava India brand, Zota Healthcare is now committed to give its leniency to the generic sector as well.

Dava India aims at opening more than 3000 generic drug stores across India and worldwide in the next 2-3 years. The brand will offer more than 1200 drugs, 300 cosmetic products, surgical products, nutritious herbal medicines, taking care of all the needs of its consumers.

Further, the brand has also a provision for a ‘Customer Care Center’ that will help in resolving the customer queries regularly, generating a sense of trust and care among its customers. It plans to develop it as a chain of stores and integrate modernity, quality, competence and social welfare in the medical world.

Franchise 100

The Franchising World, India’s no.1 Franchising Magazine, identifies the TOP 100 Franchise Brands and celebrates their achievements every year in its anniversary issue. The issue highlights the established Indian and big global brands that are increasing their positioning in India along with the new-age brands that are lucrative and profitable, expanding fast, as a reference guide for budding entrepreneurs and investors across India.

Franchise Top 100 is the one-stop destination to know everything about the franchise industry which establishes the authority, and strength to evaluate the growth of the franchise industry.

Subscribe Newsletter
Submit your email address to receive the latest updates on news & host of opportunities
Entrepreneur Magazine

For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you

or Click here to Subscribe Online

Newsletter Signup

Share your email address to get latest update from the industry